Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Alzheimer's Disease
100%
Neuroimaging
100%
Mild Cognitive Impairment
57%
Entorhinal Cortex
42%
High Risk
14%
Single-photon Emission Computed Tomography (SPECT)
14%
Microglial Activation
14%
Alzheimer's Disease Patient
14%
Cognitive Impairment
14%
Atrophy
14%
Super-elderly
14%
Autosomal Dominant
14%
Functional Magnetic Resonance Imaging
14%
Enzymatic Activity
14%
Activation Mechanism
14%
Structural Magnetic Resonance Imaging (sMRI)
14%
Saving Time
14%
New Therapies
14%
Neuroimaging Techniques
14%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
14%
Clinical Onset
14%
Early Markers
14%
Likelihood Ratio
14%
Activation Paradigm
14%
Cortex Activation
14%
Regional Metabolism
14%
Limbic Areas
14%
Temporal Association Cortex
14%
Medial Temporal
14%
Regional Perfusion
14%
Brain Atrophy
14%
Brain Pathology
14%
Atrophy Rate
14%
H215O PET
14%
Regional Deposition
14%
Saving Resources
14%
Temporal Structure
14%
Medicine and Dentistry
Alzheimer's Disease
100%
Polyethylene Terephthalate
50%
Mild Cognitive Impairment
50%
Entorhinal Cortex
37%
Magnetic Resonance Imaging
12%
Amyloid Protein
12%
Single-Photon Emission Computed Tomography
12%
Enzyme Activity
12%
Functional Magnetic Resonance Imaging
12%
Cognitive Defect
12%
Autosomal Dominant Inheritance
12%
Regional Perfusion
12%
Cerebral Atrophy
12%
Association Cortex
12%
Neuroscience
Alzheimer's Disease
100%
Positron Emission Tomography
50%
Mild Cognitive Impairment
50%
Entorhinal Cortex
37%
Metabolic Pathway
12%
Enzyme Activity
12%
Single-Photon Emission Computed Tomography
12%
Amyloid Protein
12%
Cognitive Disorder
12%
Magnetic Resonance Imaging
12%
Functional Magnetic Resonance Imaging
12%
Association Cortex
12%